首页> 中文期刊> 《中华医学杂志(英文版) 》 >Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs

Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs

         

摘要

Background Changing health care providers frequently breaks the continuity of care,which is associated with many health care problems.The purpose of this study was to examine the association between a change of health care providers and pregnancy exposure to FDA category C,D and X drugs.Methods A 50% random sample of women who gave a birth in Saskatchewan between January 1,1997 and December 31,2000 were chosen for this study.The association between the number of changes in health care providers and with pregnancy exposure to category C,D,and X drugs for those women with and without chronic diseases were evaluated using multiple logistical regression,with adjusted odds ratios (ORs) and its 95% confidence intervals (C/s) as the association measures.Results A total of 18 568 women were included in this study.Rates of FDA C,D,and X drug uses were 14.35%,17.07%,21.72%,and 31.14%,in women with no change of provider,1-2 changes,3-5 changes,and more than 5 changes of health care providers.An association between the number of changes of health care providers and pregnancy exposure to FDA C,D,and X drugs existed in women without chronic diseases but not in women with chronic disease.Conclusion Change of health care providers is associated with pregnancy exposure to FDA category C,D and X drugs in women without chronic diseases.

著录项

  • 来源
    《中华医学杂志(英文版) 》 |2014年第4期|702-706|共5页
  • 作者单位

    School of Public Health, Central South University, Changsha, Hunan 410008, China;

    Department of Preventive Medicine, Changzhi Medical College,Changzhi, Shanxi 046000, China;

    McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada;

    OMNI Research Group, Department of Obstetrics and Gynecology,University of Ottawa Faculty of Medicine, Ottawa, Canada;

    OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada;

    Huaihua Medical College, Huaihua, Hunan 418000, China;

    McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada;

    Department of Cardiology, Heping Hospital, Changzhi Medical College, Changzhi, Shanxi 046000, China;

    OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada;

    Ottawa Hospital Research Institute, Clinical Epidemiology Program,Ottawa, Canada;

    Department of Preventive Medicine, Changzhi Medical College,Changzhi, Shanxi 046000, China;

    School of Public Health, Central South University, Changsha, Hunan 410008, China;

    OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada;

    Ottawa Hospital Research Institute, Clinical Epidemiology Program,Ottawa, Canada;

    Department of Epidemiology and Community Medicine, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号